Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $30,200 | 11 | 81.5% |
| Travel and Lodging | $5,260 | 18 | 14.2% |
| Food and Beverage | $1,582 | 26 | 4.3% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $36,588 | 42 | $0 (2022) |
| Abbott Laboratories | $377.00 | 8 | $0 (2019) |
| Siemens Medical Solutions USA, Inc. | $31.76 | 2 | $0 (2019) |
| Lantheus Medical Imaging, Inc. | $19.13 | 1 | $0 (2019) |
| BOSTON SCIENTIFIC CORPORATION | $13.26 | 1 | $0 (2017) |
| Amgen Inc. | $12.70 | 1 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2022 | $21.46 | 1 | PFIZER INC. ($21.46) |
| 2020 | $9,247 | 14 | PFIZER INC. ($9,247) |
| 2019 | $27,665 | 37 | PFIZER INC. ($27,237) |
| 2018 | $82.88 | 1 | PFIZER INC. ($82.88) |
| 2017 | $25.96 | 2 | BOSTON SCIENTIFIC CORPORATION ($13.26) |
All Payment Transactions
55 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 01/04/2022 | PFIZER INC. | VYNDAQEL (Drug) | Travel and Lodging | In-kind items and services | $21.46 | General |
| Category: CARDIOVASCULAR | ||||||
| 05/15/2020 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $700.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 04/01/2020 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,275.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/18/2020 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/16/2020 | PFIZER INC. | VYNDAQEL (Drug) | Travel and Lodging | In-kind items and services | $38.81 | General |
| Category: CARDIOVASCULAR | ||||||
| 03/11/2020 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $107.57 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/29/2020 | PFIZER INC. | VYNDAQEL (Drug) | Travel and Lodging | In-kind items and services | $854.98 | General |
| Category: CARDIOVASCULAR | ||||||
| 02/26/2020 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/27/2020 | PFIZER INC. | ELIQUIS (Drug), VYNDAQEL | Food and Beverage | In-kind items and services | $12.80 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 01/16/2020 | PFIZER INC. | VYNDAQEL (Drug) | Travel and Lodging | In-kind items and services | $561.16 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/16/2020 | PFIZER INC. | VYNDAQEL (Drug) | Travel and Lodging | In-kind items and services | $437.19 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/16/2020 | PFIZER INC. | VYNDAQEL (Drug) | Travel and Lodging | In-kind items and services | $235.85 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/16/2020 | PFIZER INC. | VYNDAQEL (Drug) | Travel and Lodging | In-kind items and services | $130.42 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/16/2020 | PFIZER INC. | VYNDAQEL (Drug) | Travel and Lodging | In-kind items and services | $120.07 | General |
| Category: CARDIOVASCULAR | ||||||
| 01/10/2020 | PFIZER INC. | VYNDAQEL (Drug) | Travel and Lodging | In-kind items and services | $23.55 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/26/2019 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/18/2019 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $112.27 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/18/2019 | PFIZER INC. | VYNDAQEL (Drug) | Travel and Lodging | In-kind items and services | $29.58 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/18/2019 | PFIZER INC. | VYNDAQEL (Drug) | Travel and Lodging | In-kind items and services | $20.88 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/06/2019 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 12/04/2019 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $89.75 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/27/2019 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,625.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/12/2019 | PFIZER INC. | VYNDAQEL (Drug) | Food and Beverage | In-kind items and services | $110.17 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/11/2019 | PFIZER INC. | VYNDAQEL (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,275.00 | General |
| Category: CARDIOVASCULAR | ||||||
| 11/09/2019 | PFIZER INC. | VYNDAQEL (Drug) | Travel and Lodging | In-kind items and services | $722.70 | General |
| Category: CARDIOVASCULAR | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 17 | 1,378 | 1,510 | $481,770 | $73,195 |
| 2022 | 17 | 690 | 949 | $231,744 | $34,756 |
| 2021 | 16 | 1,021 | 1,219 | $335,281 | $45,272 |
| 2020 | 17 | 1,024 | 1,189 | $335,415 | $48,437 |
All Medicare Procedures & Services
73 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 402 | 413 | $176,764 | $21,773 | 12.3% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 203 | 205 | $87,740 | $10,133 | 11.5% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 25 | 60 | $19,388 | $5,743 | 29.6% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 32 | 81 | $16,643 | $5,034 | 30.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 48 | 70 | $9,273 | $4,998 | 53.9% |
| 93312 | Ultrasound of heart with probe in esophagus, with report | Facility | 2023 | 58 | 58 | $36,250 | $4,864 | 13.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 33 | 33 | $10,296 | $4,273 | 41.5% |
| 76377 | 3d radiographic procedure with computerized image postprocessing | Facility | 2023 | 97 | 97 | $26,966 | $2,848 | 10.6% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 19 | 19 | $10,797 | $2,692 | 24.9% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 27 | 27 | $5,529 | $2,682 | 48.5% |
| 76377 | 3d radiographic procedure with computerized image postprocessing | Office | 2023 | 91 | 91 | $25,298 | $2,533 | 10.0% |
| 99238 | Hospital discharge day management, 30 minutes or less | Facility | 2023 | 35 | 36 | $7,864 | $2,334 | 29.7% |
| 93308 | Ultrasound of heart, follow-up | Facility | 2023 | 44 | 48 | $9,024 | $936.96 | 10.4% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Facility | 2023 | 16 | 16 | $12,656 | $854.10 | 6.7% |
| 93321 | Ultrasound of heart blood flow, valves and chambers, follow-up | Facility | 2023 | 72 | 75 | $7,800 | $420.55 | 5.4% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Facility | 2023 | 18 | 18 | $2,196 | $264.32 | 12.0% |
| 93325 | Ultrasound of heart with color-depicted blood flow, rate and valve function | Facility | 2023 | 107 | 112 | $8,400 | $261.08 | 3.1% |
| 93320 | Ultrasound of heart blood flow, valves and chambers | Facility | 2023 | 18 | 18 | $4,464 | $239.02 | 5.4% |
| 93356 | Heart muscle strain imaging | Office | 2023 | 19 | 19 | $2,546 | $179.36 | 7.0% |
| 93356 | Heart muscle strain imaging | Facility | 2023 | 14 | 14 | $1,876 | $132.16 | 7.0% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2022 | 255 | 260 | $99,893 | $13,544 | 13.6% |
| 93798 | Outpatient heart rehabilitation with electrocardiogram (ecg) monitoring, quality health care professional services | Office | 2022 | 15 | 185 | $13,690 | $3,744 | 27.3% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 13 | 39 | $19,311 | $3,253 | 16.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 51 | 58 | $20,996 | $2,379 | 11.3% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 15 | 34 | $9,072 | $1,891 | 20.8% |
About Dr. Christopher Gans, M.D
Dr. Christopher Gans, M.D is a Cardiovascular Disease healthcare provider based in Ann Arbor, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/29/2007. The National Provider Identifier (NPI) number assigned to this provider is 1790986644.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Christopher Gans, M.D has received a total of $37,042 in payments from pharmaceutical and medical device companies, with $21.46 received in 2022. These payments were reported across 55 transactions from 6 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($30,200).
As a Medicare-enrolled provider, Gans has provided services to 4,113 Medicare beneficiaries, totaling 4,867 services with total Medicare billing of $201,660. Data is available for 4 years (2020–2023), covering 73 distinct procedure/service records.
Practice Information
- Specialty Cardiovascular Disease
- Other Specialties Cardiovascular Disease, Internal Medicine
- Location Ann Arbor, MI
- Active Since 05/29/2007
- Last Updated 10/18/2022
- Taxonomy Code 207RC0000X
- Entity Type Individual
- NPI Number 1790986644
Products in Payments
- VYNDAQEL (Drug) $36,478
- Mitra Clip system (Device) $377.00
- SC2000 (Device) $31.76
- ELIQUIS (Drug) $27.26
- Definity (Drug) $19.13
- WATCHMAN (Device) $13.26
- Corlanor (Drug) $12.70
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Cardiovascular Disease Doctors in Ann Arbor
Jackson Liang, D.o, D.O
Cardiovascular Disease — Payments: $226,408
Hakan Oral, Md, MD
Cardiovascular Disease — Payments: $86,902
Kelly Arps, Md, MD
Cardiovascular Disease — Payments: $62,363
Dr. George Hanna, Md, MD
Cardiovascular Disease — Payments: $41,342
Prasanthi Yelavarthy
Cardiovascular Disease — Payments: $26,341
Gary Hammer, Md, MD
Cardiovascular Disease — Payments: $15,290